Margret Schottelius

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

Martina Weineisen, Margret Schottelius, Jakub Šimeček et al. · Journal of Nuclear Medicine · 2015 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

Richard P. Baum, Harshad Kulkarni, Christiane Schuchardt et al. · Journal of Nuclear Medicine · 2016 · 526 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Ligands for Mapping α_vβ₃-Integrin Expression in Vivo

Margret Schottelius, Burkhardt Laufer, Horst Kessler et al. · Accounts of Chemical Research · 2009 · 290 citations

Life Sciences, Molecular Biology, Oncology +17

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with ¹⁷⁷Lu- and ⁹⁰Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

Ken Herrmann, Margret Schottelius, Constantin Lapa et al. · Journal of Nuclear Medicine · 2015 · 269 citations · Full text

Medicine, Oncology, Radiation Oncology +16

99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer

Tobias Maurer, Stephanie Robu, Margret Schottelius et al. · European Urology · 2018 · 246 citations

Medicine, Radiology, Urology +14